RadNet, Inc. Profile Avatar - Palmy Investing

RadNet, Inc.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultraso…
Medical - Diagnostics & Research
US, Los Angeles [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 50% Balanced
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 40.45 1.86 1.32
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 14.04 16.93 14.85
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 35.61 12.60 9.29
Cash 50.72 7.60 5.04
Capex -40.40 -0.83 -0.59
Free Cash Flow -19.13 -0.58 0.72
Revenue 0.62 6.23 6.19
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -63.22 0.03 0.07
Operating Margin -63.22 0.03 0.07
ROA -45.24 < 0.005 < 0.005
ROE -7.95 < 0.005 < 0.005
ROIC -44.45 0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of RDNT is permitted for members.
5 Growth
The "Growth Entry" for the Focus of RDNT is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of RDNT is permitted for members.
End of RDNT's Analysis
CIK: 790526 CUSIP: 750491102 ISIN: US7504911022 LEI: - UEI: -
Secondary Listings
RDNT has no secondary listings inside our databases.